CLARIO
LIVE

Serial Number

97107116

Owner

eResearchTechnology, Inc.

Attorney

David M. Kramer

Filing Date

Nov 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CLARIO Trademark

Serial Number: 97107116

CLARIO is a trademark filed by eResearchTechnology, Inc. on November 3, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

eResearchTechnology, Inc. (35 trademarks)

1818 Market Street, Suite 2600
Philadephia, PA 19103-3638

Entity Type: 03

Trademark Details

Filing Date

November 3, 2021

Registration Date

Not Registered

Published for Opposition

January 3, 2023

Goods & Services

Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship

Data automation and collection service using proprietary software to evaluate, analyze and collect service data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship

Filing History

SOU TEAS EXTENSION RECEIVED
May 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 2, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 1, 2026 EX4G
SOU EXTENSION 4 FILED
Nov 6, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 14, 2025 EX3G
SOU TEAS EXTENSION RECEIVED
May 5, 2025 EEXT
SOU EXTENSION 3 FILED
May 4, 2025 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2024 EXRA
SOU EXTENSION 2 GRANTED
Nov 5, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 5, 2024 EEXT
CORRECTED NOA E-MAILED
Apr 23, 2024 NOAC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 22, 2024 EX1G
DIVISIONAL PROCESSING COMPLETE
Apr 22, 2024 DPCC
RESPONSE TO ITU OFFICE ACTION ENTERED
Apr 17, 2024 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2024 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Apr 16, 2024 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 8, 2024 AITU
SOU EXTENSION 1 FILED
Mar 20, 2024 EXT1
DIVISIONAL REQUEST RECEIVED
Mar 20, 2024 DRRR
SOU TEAS EXTENSION RECEIVED
Mar 20, 2024 EEXT
TEAS REQUEST TO DIVIDE RECEIVED
Mar 20, 2024 ERTD
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 22, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 22, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 22, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 7, 2023 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Sep 25, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
Sep 25, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Sep 25, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
Jun 26, 2023 OP.I
POST PUBLICATION AMENDMENT - ENTERED
May 23, 2023 CHPB
ASSIGNED TO PETITION STAFF
May 22, 2023 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 4, 2023 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 20, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 29, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 29, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 29, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 25, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 25, 2022 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Oct 13, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 7, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 22, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2022 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 18, 2022 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 18, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2021 REAP
NEW APPLICATION ENTERED
Nov 6, 2021 NWAP